Single-dose oral ciprofloxacin compared with cefotaxime and placebo for prophylaxis during transurethral surgery

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue SUPPL. A, 1999, Pages 77-84

  Klimberg, Ira W ^a   Malek, G H ^b   Cox, Clair E ^c   Patterson, A Lynn ^c   Whalen, Edward ^d   Kowalsky, Steven F ^d   Echols, Roger M ^d,e  

^a Urology Center of Florida   (United States)

^b Jackson Found Med Res and Educ   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d BAYER CORPORATION   (United States)

^e BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CIPROFLOXACIN; PLACEBO;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIURIA; BLADDER TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEART ARRHYTHMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL; TRANSURETHRAL RESECTION;

ADMINISTRATION, ORAL; ADULT; AGED; ANTI-INFECTIVE AGENTS; BACTERIURIA; CEFOTAXIME; CEPHALOSPORINS; CIPROFLOXACIN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PLACEBOS; PROSTATECTOMY;

EID: 0033051328     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Holtgrewe, H. L., Mebust, W. K., Dowd, J. B., Cockett, A. T., Peters, P. C. & Proctor, C. (1989). Transurethral prostatectomy: practice aspects of the dominant operation in American urology. Journal of Urology 141, 248-53.
2. Childs, S. (1992). Current diagnosis and treatment of urinary tract infections. Urology 40, 295-9.
3. Nielsen, O. S., Maigaard, S., Frimodt-Moller, N. & Madsen, P. O. (1981). Prophylactic antibiotics in transurethral prostatectomy. Journal of Urology 126, 60-2.
4. Korbel, E. I. & Maher, P. O. (1976). Use of prophylactic antibiotics in urethral instrumentation. Journal of Urology 116, 744-6.
5. Flynn, N. M. & Lawrence, R. M. (1979). Antimicrobial prophylaxis. Medical Clinics of North America 63, 1225-44.
6. Botto, H., Richard, F., Mathieu, F., Perreau, A. M. & Camey, M. (1984). Short-term prophylaxis with cefotaxime in prostatic surgery. Journal of Antimicrobial Chemotherapy 14, Suppl. B, 231-5.
7. Christensen, M. M. (1991). Antimicrobial prophylaxis in transurethral resection of the prostate. With special reference to preoperatively sterile urine. Scandinavian Journal of Urology and Nephrology 25, 169-74.
8. Charton, M., Vallancien, G., Veillon, B. & Brisset, J. M. (1987). Antibiotic prophylaxis of urinary tract infection after transurethral resection of the prostate: a randomized study. Journal of Urology 138, 87-9.
9. Grabe, M. (1987). Antimicrobial agents in transurethral prostatic resection. Journal of Urology 138, 245-52.
10. Falkiner, F. R., Ma, P. T., Murphy, D. M., Cafferkey, M. T. & Gillespie, W. A. (1983). Antimicrobial agents for the prevention of urinary tract infection in transurethral surgery. Journal of Urology 129, 766-8.
11. Prokocimer, P., Quazza, M., Gibert, C., Lemoine, J. E., Joly, M. L., Dureuil, B. et al. (1986). Short-term prophylactic antibiotics in patients undergoing prostatectomy: report of a double-blind randomized trial with 2 intravenous doses of cefotaxime. Journal of Urology 135, 60-4.
12. Desai, K. M., Abrams, P. H. & White, L. O. (1988). A double-blind comparative trial of short-term orally administered enoxacin in the prevention of urinary infection after elective transurethral prostatectomy: a clinical and pharmacokinetic study. Journal of Urology 139, 1232-4.
13. Shearman, C. P., Silverman, S. H., Johnson, M., Young, C. H., Farrar, D. J., Keighley, M. R. et al. (1988). Single dose, oral antibiotic cover for transurethral prostatectomy. British Journal of Urology 62, 434-8.
14. Dorflinger, T. & Madsen, P. O. (1984). Antibiotic prophylaxis in transurethral surgery. Urology 24, 643-6.
15. Finkelstein, L. H., Arsht, D. B., Manfrey, S. J. & Childs, S. (1984). Ceftriaxone in the prevention of postoperative infection in patients undergoing transurethral resection of the prostate. American Journal of Surgery 148, 19-21.
16. Upton, J. D. & Das, S. (1986). Prophylactic antibiotics in transurethral resection of bladder tumors: are they necessary? Urology 27, 421-3.
17. Slavis, S. A., Miller, J. B., Golji, H. & Dunshee, C. J. (1992). Comparison of single-dose antibiotic prophylaxis in uncomplicated transurethral resection of the prostate. Journal of Urology 147, 1303-6.
18. Rocca Rossetti, S., Boccafoschi, C., Pellegrini, A., Campo, B., Rigatti, P., Bono, A. et al. (1991). Aztreonam monotherapy as prophylaxis in transurethral resection of the prostate: a multicenter study. Reviews of Infectious Diseases 13, Suppl. 7, S626-8.
19. Qvist, N., Christiansen, H. M. & Ehlers, D. (1984). Prophylactic antibiotics in transurethral prostatectomy. Urological Research 12, 275-7.
20. Goldwasser, B., Bogokowsky, B., Nativ, O., Sidi, A. A., Jonas, P. & Many, M. (1983). Urinary infections following transurethral resection of bladder tumors - rate and source. Journal of Urology 129, 1123-4.
21. Gorelick, J. I., Senterfit, L. B. & Vaughan, E. D. (1988). Quantitative bacterial tissue cultures from 209 prostatectomy specimens: findings and implications. Journal of Urology 139, 57-60.
22. Robinson, M. R., Arudpragasam, S. T., Sahgal, S. M., Cross, R. J., Akdas, A., Fittal, B. et al. (1982). Bacteraemia resulting from prostatic surgery: the source of bacteria. British Journal of Urology 54, 542-6.
23. Eliopoulos, G. M. & Eliopoulos, C. T. (1993). Activity in vitro of the quinlones. In Ouinolone Antimicrobial Agents, 2nd edn (Hooper, D. C. and Wilson, J. S., Eds), pp. 161-93. American Society for Microbiology, Washington, DC.
24. Gombert, M. E., du Bouchet, L., Aulicino, T. M., Berkowitz, L. B. & Macchia, R. J. (1987). Brief report: prostatic tissue concentrations of ciprofloxacin after oral administration. American Journal of Medicine 82, Suppl. 4A, 130S-2S.
25. Dan, M., Golomb, J., Gorea, A., Braf, Z. & Berger, S. A. (1986). Concentration of ciprofloxacin in human prostatic tissue after oral administration. Antimicrobial Agents and Chemotherapy 30, 88-9.
26. Grabe, M., Forsgren, A. & Bjork, T. (1986). Concentrations of ciprofloxacin in serum and prostatic tissue in patients undergoing transurethral resection. European Journal of Clinical Microbiology 5, 211-12.
27. Naber, K. G., Sorgel, F., Kinzig, M. & Weigel, D. M. (1993). Penetration of ciprofloxacin into prostatic fluid, ejaculate and seminal fluid in volunteers after an oral dose of 750 mg. Journal of Urology 150, 1718-21.
28. Food and Drug Administration (1994). Summary basis for approval for cefotaxime NDA 50-547. FDA, Washington, DC.